{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:52:52Z","timestamp":1782867172553,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T00:00:00Z","timestamp":1679788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004833","name":"State of New Jersey Commission on Science and Technology","doi-asserted-by":"publisher","award":["DCHS19PPC027"],"award-info":[{"award-number":["DCHS19PPC027"]}],"id":[{"id":"10.13039\/100004833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007558","name":"Rutgers Cancer Institute of New Jersey","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011132","name":"Rutgers, The State University of New Jersey","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["101BX003742"],"award-info":[{"award-number":["101BX003742"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CCSG P30CA072720-5917"],"award-info":[{"award-number":["CCSG P30CA072720-5917"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R44CA156781-04"],"award-info":[{"award-number":["R44CA156781-04"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jid.2023.03.1664","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T03:40:08Z","timestamp":1680061208000},"page":"2007-2018.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Spontaneous Melanoma Mouse Model Applicable for a Longitudinal Chemotherapy and Immunotherapy Study"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3531-6331","authenticated-orcid":false,"given":"Kevinn","family":"Eddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0665-1539","authenticated-orcid":false,"given":"Kajal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0397-0681","authenticated-orcid":false,"given":"Jeffrey C.","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3633-9084","authenticated-orcid":false,"given":"Allison L.","family":"Isola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1979-0167","authenticated-orcid":false,"given":"Christina","family":"Marinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6816-477X","authenticated-orcid":false,"given":"Maryam Abdur","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9672-4702","authenticated-orcid":false,"given":"Joseph","family":"Campagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8982-6025","authenticated-orcid":false,"given":"Mohamad Naser","family":"Eddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3996-8097","authenticated-orcid":false,"given":"Marco","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1801-434X","authenticated-orcid":false,"given":"Anna","family":"Fateeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Reuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0440-0189","authenticated-orcid":false,"given":"Raj","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3919-2911","authenticated-orcid":false,"given":"Ann K.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6726-7063","authenticated-orcid":false,"given":"Anna","family":"Chaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4021-8808","authenticated-orcid":false,"given":"Katie B.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3759-1900","authenticated-orcid":false,"given":"Wenjin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3780-3726","authenticated-orcid":false,"given":"Jesus","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3931-3004","authenticated-orcid":false,"given":"Philip","family":"Furmanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3877-3984","authenticated-orcid":false,"given":"Ann W.","family":"Silk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2780-4044","authenticated-orcid":false,"given":"Allen B.","family":"Reitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-6493","authenticated-orcid":false,"given":"Andrew","family":"Zloza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6384-5081","authenticated-orcid":false,"given":"Suzie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2023.03.1664_bib1","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00262-012-1290-9","article-title":"Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma","volume":"61","author":"Alb","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jid.2023.03.1664_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1200\/EDBK_349557","article-title":"Immune checkpoint blockade therapy in patients with colorectal cancer harboring microsatellite instability\/mismatch repair deficiency in 2022","volume":"42","author":"Andr\u00e9","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.jid.2023.03.1664_bib3","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability\u2013high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2023.03.1664_bib4","doi-asserted-by":"crossref","first-page":"67355","DOI":"10.18632\/oncotarget.18641","article-title":"Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device","volume":"8","author":"Aya-Bonilla","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2023.03.1664_bib5","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2023.03.1664_bib6","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.euf.2020.10.009","article-title":"Partial response and stable disease correlate with positive outcomes in atezolizumab-treated patients with advanced urinary tract carcinoma","volume":"7","author":"Bedke","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.jid.2023.03.1664_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jdermsci.2008.08.012","article-title":"The hairless mouse in skin research","volume":"53","author":"Benavides","year":"2009","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2023.03.1664_bib8","article-title":"Landscape of microsatellite instability across 39 cancer types","volume":"2017","author":"Bonneville","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jid.2023.03.1664_bib9","doi-asserted-by":"crossref","first-page":"9567","DOI":"10.1200\/JCO.2021.39.15_suppl.9567","article-title":"Pathology of durable stable disease in melanoma patients treated with ipilimumab, nivolumab, or ipilimumab, and nivolumab combination therapy","volume":"39","author":"Buchbinder","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2023.03.1664_bib10","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1038\/s41467-020-17981-0","article-title":"Strength of immune selection in tumors varies with sex and age","volume":"11","author":"Castro","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2023.03.1664_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/CMR.0000000000000652","article-title":"Nonhomologous end-joining repair is likely involved in the repair of double-stranded DNA breaks induced by riluzole in melanoma cells","volume":"30","author":"Cerchio","year":"2020","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jid.2023.03.1664_bib12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/1523-1747.ep12340194","article-title":"Spontaneous melanocytosis in transgenic mice","volume":"106","author":"Chen","year":"1996","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.03.1664_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/neu.2012.2587","article-title":"The dual cyclooxygenase\/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord","volume":"30","author":"Dulin","year":"2013","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.jid.2023.03.1664_bib14","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.3390\/ijms21238984","article-title":"Overcoming immune evasion in melanoma","volume":"21","author":"Eddy","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2023.03.1664_bib15","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.3390\/cancers13153874","article-title":"Glutamatergic signaling a therapeutic vulnerability in melanoma","volume":"13","author":"Eddy","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jid.2023.03.1664_bib16","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.3390\/cells11182857","article-title":"Implications of a neuronal receptor family, metabotropic glutamate receptors, in cancer development and progression","volume":"11","author":"Eddy","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jid.2023.03.1664_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2023.03.1664_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/734515","article-title":"Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy","volume":"2014","author":"Escors","year":"2014","journal-title":"New J Sci"},{"key":"10.1016\/j.jid.2023.03.1664_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ejca.2021.08.013","article-title":"Long-term outcomes in patients with advanced melanoma who had initial stable disease with pembrolizumab in KEYNOTE-001 and KEYNOTE-006","volume":"157","author":"Hamid","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2023.03.1664_bib20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jid.2023.03.1664_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00262-014-1652-6","article-title":"The prognostic significance of stable disease following high-dose interleukin-2 (IL-2) treatment in patients with metastatic melanoma and renal cell carcinoma","volume":"64","author":"Hughes","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jid.2023.03.1664_bib22","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1002\/cpim.45","article-title":"Isolation of murine skin resident and migratory dendritic cells via enzymatic digestion","volume":"121","author":"Kashem","year":"2018","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.jid.2023.03.1664_bib23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/CMR.0000000000000298","article-title":"Microsatellite instability in melanoma: a comprehensive review","volume":"26","author":"Kube\u010dek","year":"2016","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jid.2023.03.1664_bib24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.celrep.2014.03.039","article-title":"Isolation and molecular characterization of circulating melanoma cells","volume":"7","author":"Luo","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2023.03.1664_bib25","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1038\/jid.2015.241","article-title":"Impaired gp100-specific CD8(+) T-cell responses in the presence of myeloid-derived suppressor cells in a spontaneous mouse melanoma model","volume":"135","author":"Mairhofer","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.03.1664_bib26","first-page":"379","article-title":"Synergy\u00a0between glutamate modulation and anti-programmed cell death\u00a0protein 1 immunotherapy for glioblastoma","volume":"136","author":"Medikonda","year":"2022","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.jid.2023.03.1664_bib27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/pcmr.12694","article-title":"A\u00a0phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma","volume":"31","author":"Mehnert","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2023.03.1664_bib28","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1158\/2326-6066.CIR-18-0874","article-title":"An improved patient-derived xenograft humanized mouse model for evaluation of lung cancer immune responses","volume":"7","author":"Meraz","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jid.2023.03.1664_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110331","article-title":"PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes","volume":"38","author":"Nagasaki","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2023.03.1664_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/mi10030207","article-title":"Mechanophenotyping of B16 melanoma cell variants for the assessment of the efficacy of (-)-epigallocatechin gallate treatment using a tapered microfluidic device","volume":"10","author":"Nakamura","year":"2019","journal-title":"Micromachines (Basel)"},{"key":"10.1016\/j.jid.2023.03.1664_bib31","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/0008-5472.CAN-06-3665","article-title":"Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma","volume":"67","author":"Namkoong","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2023.03.1664_bib32","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31770","article-title":"Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade","volume":"7","author":"Natale","year":"2018","journal-title":"ELife"},{"key":"10.1016\/j.jid.2023.03.1664_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/35095108","article-title":"Neonatal sunburn and melanoma in mice","volume":"413","author":"Noonan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jid.2023.03.1664_bib34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3389\/fimmu.2019.01076","article-title":"Editorial: sex hormones and gender differences in immune responses","volume":"10","author":"Ortona","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2023.03.1664_bib35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ccell.2021.01.011","article-title":"Melanoma models for the next generation of therapies","volume":"39","author":"Patton","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2023.03.1664_bib36","doi-asserted-by":"crossref","first-page":"E4041","DOI":"10.1073\/pnas.1720948115","article-title":"Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment","volume":"115","author":"Peranzoni","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2023.03.1664_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/ng1148","article-title":"Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia","volume":"34","author":"Pollock","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2023.03.1664_bib38","article-title":"Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy","volume":"9","author":"Prokopi","year":"2021","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.jid.2023.03.1664_bib39","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","article-title":"iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics","volume":"18","author":"Seymour","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2023.03.1664_bib40","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1158\/0008-5472.CAN-18-1500","article-title":"Concurrent targeting of glutaminolysis and metabotropic glutamate receptor 1 (GRM1) reduces glutamate bioavailability in GRM1+ melanoma","volume":"79","author":"Shah","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2023.03.1664_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41389-018-0098-7","article-title":"Participation of xCT in melanoma cell proliferation in\u00a0vitro and tumorigenesis in\u00a0vivo","volume":"7","author":"Shin","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.jid.2023.03.1664_bib42","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1755-148X.2008.00452.x","article-title":"Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation","volume":"21","author":"Shin","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2023.03.1664_bib43","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jid.2023.03.1664_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s40001-022-00732-w","article-title":"A\u00a0phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors","volume":"27","author":"Silk","year":"2022","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jid.2023.03.1664_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jid.2023.03.1664_bib46","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00262-017-2065-0","article-title":"Clinical evaluation of macrophages in cancer: role in treatment, modulation and challenges","volume":"66","author":"Tremble","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jid.2023.03.1664_bib47","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2125.2004.02233.x","article-title":"Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis","volume":"59","author":"van Kan","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jid.2023.03.1664_bib48","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.3390\/cancers14143546","article-title":"Dynamic CD8+ T cell cooperation with macrophages and monocytes for successful cancer immunotherapy","volume":"14","author":"Vermare","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jid.2023.03.1664_bib49","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/exd.12373","article-title":"Anatomical distribution analysis reveals lack of Langerin+ dermal dendritic cells in footpads and tail of C57BL\/6 mice","volume":"23","author":"Voisin","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2023.03.1664_bib50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/pcmr.12207","article-title":"Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells","volume":"27","author":"Wall","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2023.03.1664_bib51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ijc.2910470211","article-title":"Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line","volume":"47","author":"Welch","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2023.03.1664_bib52","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2023.03.1664_bib53","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJM195904162601601","article-title":"Studies on melanoma. II. Sex and survival in human melanoma","volume":"260","author":"White","year":"1959","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2023.03.1664_bib54","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1158\/1078-0432.CCR-09-1624","article-title":"Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria","volume":"15","author":"Wolchok","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2023.03.1664_bib55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4939-9145-7_15","article-title":"Creation of PDX-bearing humanized mice to study immuno-oncology","volume":"1953","author":"Yao","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jid.2023.03.1664_bib56","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/s41467-020-15679-x","article-title":"Sex-associated molecular differences for cancer immunotherapy","volume":"11","author":"Ye","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2023.03.1664_bib57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1523-1747.1998.00133.x","article-title":"Development of heritable melanoma in transgenic mice","volume":"110","author":"Zhu","year":"1998","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23019516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23019516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:52:01Z","timestamp":1762206721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X23019516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0022202X23019516"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2023.03.1664","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Spontaneous Melanoma Mouse Model Applicable for a Longitudinal Chemotherapy and Immunotherapy Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2023.03.1664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}